Neonatal tetanus deaths ‐ 1 dose · women aged between 13 and 45 years.
Tetanus toxoid showed no clear difference in neonatal tetanus deaths ‐ 1 dose compared with influenza vaccine (low certainty).
1 finding from 1 review
Neonatal tetanus deaths ‐ 2 or 3 doses · women aged between 13 and 45 years.
Tetanus toxoid probably leads to lower neonatal tetanus deaths ‐ 2 or 3 doses compared with influenza vaccine (moderate certainty).
1 finding from 1 review
All causes of deaths ‐ 1 dose · women aged between 13 and 45 years.
Tetanus toxoid showed no clear difference in all causes of deaths ‐ 1 dose compared with influenza vaccine (low certainty).
1 finding from 1 review
All causes of deaths ‐ 2 or 3 doses · women aged between 13 and 45 years.
Tetanus toxoid probably leads to lower all causes of deaths ‐ 2 or 3 doses compared with influenza vaccine (moderate certainty).
1 finding from 1 review
Neonatal tetanus cases ‐ Any dose · women aged between 13 and 45 years.
Tetanus toxoid probably leads to lower neonatal tetanus cases ‐ Any dose compared with influenza vaccine (moderate certainty).
1 finding from 1 review
Intervention not reported
Medicine use · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall use of medicines · vulnerable population: senior 65 years of age or older
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Use of medicines for symptomatic conditions · vulnerable population: senior 65 years of age or older
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Use of medicines for asymptomatic conditions · vulnerable population: senior 65 years of age or older
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Cost · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Patient perspective · vulnerable population: senior 65 years of age or older
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Insurer perspective (expenditures on medicines) · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Insurer perspective (expenditures on health care) · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Healthcare utilisation · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall healthcare utilisation · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Emergency department and hospitalisation · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Outpatient care · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health outcomes · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Function (overall) Various tools · adults (aged ≥ 16 years) with acute middle third clavicle fractures
Intramedullary fixation may leads to higher function or disability (overall) Various tools (Constant score and… compared with open reduction and internal fixation with plate (low certainty).
1 finding from 1 review
Pain ‐ using the section of Constant score Scale from 0 to 15; with 15 being the best positive score · adults (aged ≥ 16 years) with acute middle third clavicle fractures
It is very uncertain whether intramedullary fixation changes pain ‐ using the section of Constant score Scale from 0 to 15; with… compared with open reduction and internal fixation with plate (very low certainty).
1 finding from 1 review